ESS
62
-3
A
37
-2
MRK
17
-5
FITB
60
-5
XEL
67
2
KEY
43
-3
ADBE
47
-9
WU
24
4
NAVI
52
-2
AME
74
-4
STX
45
-4
PYPL
52
-2
ROST
57
-3
CHD
54
4
COF
62
3
STZ
52
-6
K
51
-3
GIS
22
-4
CI
45
-3
HBI
58
3
ESS
62
-3
A
37
-2
MRK
17
-5
FITB
60
-5
XEL
67
2
KEY
43
-3
ADBE
47
-9
WU
24
4
NAVI
52
-2
AME
74
-4
STX
45
-4
PYPL
52
-2
ROST
57
-3
CHD
54
4
COF
62
3
STZ
52
-6
K
51
-3
GIS
22
-4
CI
45
-3
HBI
58
3
Financhill
Back

EverQuote Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
27

EVER
EverQuote

Last Price:
17.79
Seasonality Move:
27.4%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
27
EverQuote (EVER) is a Sell

Is EverQuote a Buy, Sell or Hold?

  • The current EverQuote [EVER] share price is $17.80. The Score for EVER is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • EVER is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EVER Stock Price Chart

What is EverQuote's stock price today?

  • The EverQuote share price today is $17.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EVER is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

EVER Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.26 Sell
Relative Strength Index (14 RSI): 43.31 Sell
Chaikin Money Flow: -372267 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.72 - 19.78) Sell
Bollinger Bands (100): (19.24 - 23.84) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

EVER Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.13 Sell
20-day SMA: 18.49 Sell
50-day SMA: 19.97 Sell
200-day SMA: 20.38 Sell
8-day EMA: 18.83 Sell
20-day EMA: 18.92 Sell
50-day EMA: 19.8 Sell
200-day EMA: 19.23 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

EverQuote Earnings Growth & EVER Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.05 per share, and an increase next year of $0.13 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

EverQuote Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):